EQL Pharma AB (publ) (STO:EQL)

EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,518	2,064	1,229	1,087	974	994
Market Cap Growth	-38.85%	67.85%	13.10%	11.64%	-2.05%	153.33%
Enterprise Value	1,882	2,205	1,317	1,075	1,010	980
Last Close Price	51.40	71.00	42.30	37.40	33.50	34.20
PE Ratio	52.47	47.85	54.15	35.15	30.86	95.88
PS Ratio	3.57	5.53	4.65	4.18	2.38	5.55
PB Ratio	5.63	9.34	6.92	7.02	7.88	10.90
P/TBV Ratio	-	-	42.91	20.82	38.62	-
P/FCF Ratio	-	-	-	40.02	23.63	16.67
P/OCF Ratio	-	-	-	39.36	23.28	16.55
EV/Sales Ratio	4.42	5.90	4.99	4.14	2.47	5.47
EV/EBITDA Ratio	21.60	29.14	33.94	22.70	24.92	59.15
EV/EBIT Ratio	28.28	32.73	40.38	26.01	26.01	85.05
EV/FCF Ratio	-150.58	-	-	39.59	24.52	16.43
Debt / Equity Ratio	1.62	2.06	0.68	0.43	0.62	0.96
Debt / EBITDA Ratio	5.02	5.88	2.98	1.37	1.83	5.26
Debt / FCF Ratio	-	-	-	2.45	1.85	1.46
Net Debt / Equity Ratio	1.35	1.69	0.56	0.14	0.28	0.66
Net Debt / EBITDA Ratio	4.27	4.93	2.57	0.47	0.86	3.66
Net Debt / FCF Ratio	-29.15	-12.13	-8.06	0.82	0.85	1.02
Asset Turnover	0.67	0.63	0.80	0.99	1.86	1.09
Inventory Turnover	1.39	1.53	1.74	2.69	7.47	3.62
Quick Ratio	1.03	0.97	0.53	0.83	0.77	0.56
Current Ratio	2.16	1.81	1.22	1.43	1.25	1.03
Return on Equity (ROE)	12.28%	21.63%	13.66%	22.21%	29.37%	12.04%
Return on Assets (ROA)	6.53%	7.12%	6.18%	9.87%	11.00%	4.39%
Return on Invested Capital (ROIC)	8.35%	12.26%	11.40%	19.56%	21.96%	9.19%
Return on Capital Employed (ROCE)	10.40%	11.50%	15.40%	24.50%	27.90%	10.60%
Earnings Yield	1.93%	2.09%	1.85%	2.84%	3.24%	1.04%
FCF Yield	-0.82%	-1.49%	-1.01%	2.50%	4.23%	6.00%
Buyback Yield / Dilution	-0.22%	-0.34%	-0.91%	-1.59%	-	3.37%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.